Comparative assessment of the efficacy and safety of sertaconazole (2%) cream versus terbinafine cream (1%) versus luliconazole (1%) cream in patients with dermatophytoses: A pilot study

Indian Journal of Dermatology

Volumn 58, Issue 1, 2013, Pages 34-38

  Jerajani, H R ^a   Janaki, C ^b   Kumar, Sharath ^c   Phiske, Meghana ^a  

^a LOKMANYA TILAK MUNICIPAL GENERAL HOSPITAL   (India)

^b MADRAS MEDICAL COLLEGE   (India)

^c Shanmuga Nursing Home   (India)

Author keywords

Dermatophytoses; luliconazole; sertaconazole; terbinafine; tinea corporis; tinea cruris

Indexed keywords

LULICONAZOLE; SERTACONAZOLE; TERBINAFINE;

ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTACT DERMATITIS; CONTROLLED STUDY; DERMATOPHYTOSIS; DESQUAMATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OPEN STUDY; PILOT STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RELAPSE; TINEA CORPORIS; TINEA CRURIS; TREATMENT DURATION; TREATMENT WITHDRAWAL;

EID: 84872085210     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.105284     Document Type: Article

References (13)

1. Vander Straten MR, Hossain MA, Ghannoum MA. Cutaneous infections dermatophytosis, onychomycosis, and tinea versicolor. Infect Dis Clin North Am 2003;17:87-112 (Pubitemid 36514572)
2. Mohanty JC Mohanty SK, Sahoo RC, Sahoo AS, Praharaj CH. Incidence of dermatophytosis in Orissa. Indian J Med Microbiol 1998:16:78-80
3. Singh S, Beena MP. Profi le of Dermatophyte infections in Baroda. Indian J Dermatol Venereol Leprol 2003;69:281-3
4. Palacin C, Sacristan A, Ortiz JA. In vitro comparative study of the fungistatic and fungicidal activity of sertaconazole and other antifungals against Candida albicans. Arzneimittelforschung 1992;42:711-4
5. Palacin C, Tarrago C, Agut J, Guglietta A. In vitro activity of sertaconazole, fl uconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates. Methods Find Exp Clin Pharmacol 2001;23:61-4 (Pubitemid 32612683)
6. Susilo R, Korting HC, Strauss UP, Menke G, Schuster O, Menke A. Rate and extent of percutaneous absorption of sertaconazole nitrate after topical administration. Arzneimittelforschung 2005;55:338-42 (Pubitemid 40896701)
7. Agut J, Tarrida N, Sacristan A, Ortiz JA. Anti-infl ammatory activity of topically applied sertaconazole nitrate. Meth Find Exp Clin Pharmacol 1996;18:233-4 (Pubitemid 26198141)
8. Liebel F, Lyte P, Garay M, Babad J, Southall MD. Anti-infl ammatory and anti-itch activity of sertaconazole nitrate. Arch Dermatol Res 2006;298:191-9 (Pubitemid 44325631)
9. Carrillo-Muñoz AJ, Giusiano G, Ezkurra PA, Quindós G. Sertaconazole: Updated review of a topical antifungal agent. Expert Rev Anti Infect Ther 2005;3:333-42 (Pubitemid 40872528)
10. Carrillo-Muñoz AJ, Guglietta A, Palacín C, Casals J, del Valle O, Guardià C, et al. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis Chemotherapy 2004;50:308-13 (Pubitemid 40069603)
11. Savin R, Jorizzo J. The safety and effi cacy of sertaconazole nitrate cream 2% for tinea pedis. Cutis 2006;78:268-74 (Pubitemid 44720415)
12. Amber A. Kyle AA, Dahl MV. Topical Therapy for Fungal Infections. Am J Clin Dermatol 2004;5:443-51 (Pubitemid 40175262)
13. Torres J, Márquez M, Camps F. Sertaconazole in the treatment of mycoses: From dermatology to gynecology. Int J Gynecol Obstet 2000;71(Suppl 1):3-20.